Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 2
2019 2
2020 4
2021 13
2022 15
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization.
Mangioni D, Fox V, Saltini P, Lombardi A, Bussini L, Carella F, Cariani L, Comelli A, Matinato C, Muscatello A, Teri A, Terranova L, Cento V, Carloni S, Bartoletti M, Alteri C, Bandera A. Mangioni D, et al. Among authors: bussini l. Front Microbiol. 2024 Jan 11;14:1287522. doi: 10.3389/fmicb.2023.1287522. eCollection 2023. Front Microbiol. 2024. PMID: 38274761 Free PMC article.
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future.
Bavaro DF, Belati A, Bussini L, Cento V, Diella L, Gatti M, Saracino A, Pea F, Viale P, Bartoletti M. Bavaro DF, et al. Among authors: bussini l. Expert Opin Drug Saf. 2024 Jan;23(1):9-36. doi: 10.1080/14740338.2023.2299377. Epub 2023 Dec 29. Expert Opin Drug Saf. 2024. PMID: 38145925 Review.
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.
Pasquini Z, Toschi A, Casadei B, Pellegrini C, D'Abramo A, Vita S, Beccacece A, Bussini L, Chionsini MC, Dentale N, Cantiani A, Lazzarotto T, Bartoletti M, Nicastri E, Zinzani P, Giannella M, Viale P. Pasquini Z, et al. Among authors: bussini l. Hematol Oncol. 2023 Dec;41(5):904-911. doi: 10.1002/hon.3206. Epub 2023 Jul 15. Hematol Oncol. 2023. PMID: 37452579
What do clinicians mean by epidemics' preparedness.
Bartoletti M, Bussini L, Bavaro DF, Cento V. Bartoletti M, et al. Among authors: bussini l. Clin Microbiol Infect. 2024 May;30(5):586-591. doi: 10.1016/j.cmi.2023.05.030. Epub 2023 Jun 15. Clin Microbiol Infect. 2024. PMID: 37327873 Review.
Corrigendum to: "Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)" Clinical Microbiology and Infection 26 (2020) 1545-1553.
Bartoletti M, Giannella M, Scudeller L, Tedeschi S, Rinaldi M, Bussini L, Fornaro G, Pascale R, Pancaldi L, Pasquini Z, Trapani F, Badia L, Campoli C, Tadolini M, Attard L, Puoti M, Merli M, Mussini C, Menozzi M, Meschiari M, Codeluppi M, Barchiesi F, Cristini F, Saracino A, Licci A, Rapuano S, Tonetti T, Gaibani P, Ranieri VM, Viale P; PREDICO study group. Bartoletti M, et al. Among authors: bussini l. Clin Microbiol Infect. 2023 Jun;29(6):817. doi: 10.1016/j.cmi.2023.02.017. Epub 2023 Mar 1. Clin Microbiol Infect. 2023. PMID: 36868355 Free PMC article. No abstract available.
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Mikulska M, Testi D, Russo C, Balletto E, Sepulcri C, Bussini L, Dentone C, Magne F, Policarpo S, Campoli C, Miselli F, Cilli A, Ghiggi C, Aquino S, Di Grazia C, Giannella M, Giacobbe DR, Vena A, Raiola AM, Bonifazi F, Zinzani P, Cavo M, Lemoli R, Angelucci E, Viale P, Bassetti M, Bartoletti M. Mikulska M, et al. Among authors: bussini l. Br J Haematol. 2023 May;201(4):628-639. doi: 10.1111/bjh.18690. Epub 2023 Feb 20. Br J Haematol. 2023. PMID: 36806152
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.
Bonazzetti C, Tazza B, Gibertoni D, Pasquini Z, Caroccia N, Fanì F, Fornaro G, Pascale R, Rinaldi M, Miani B, Gamberini C, Morelli MC, Tamé M, Busutti M, Comai G, Potena L, Borgese L, Salvaterra E, Lazzarotto T, Scudeller L, Viale P, Giannella M; CONTRAST Study Group. Bonazzetti C, et al. Clin Infect Dis. 2023 May 24;76(10):1761-1767. doi: 10.1093/cid/ciad016. Clin Infect Dis. 2023. PMID: 36636955 Free PMC article.
41 results